The objective was to determine the diagnostic value of secondary transrectal (TRUS)-guided biopsies of the prostate in men suspected of having carcinoma of the prostate and who had already submitted to ten systematic biopsies.
Method
One hundred and seventy four patients were submitted to a second set of ten systematic TRUS-guided biopsies within a 12-month time span because of an elevated serum PSA level (158 patients) or detection of a low or high grade PIN (16 patients). At least ®ve biopsies were performed in each lobe. In addition to sextant biopsies, cores were taken from the far lateral and mid region (transition zone) of the gland according to gland volume (ten cores for prostate`50 g; 12 cores in prostate b 50 g). The two sets of biopsies were processed and analysed by the same pathologist.
Results
Mean initial and follow-up PSA levels were 10.7 AE 9.0 and 10.6 AE 9.7 ng/ml, respectively, for the patients with the ®rst negative biopsy and 7.6 AE 4.2 and 8.5 AE 5.4 ng/ml, respectively for the patients with a PIN. Adenocarcinomas were detected in the second biopsy in 26 of the 158 (16.4%) patients with the ®rst negative biopsy and in 5 of the 16 (31%) patients with a PIN at the ®rst biopsy. Low grade PIN and high grade PIN was observed in 10 (6.3%) and 4 (2.5%) patients with the ®rst negative biopsy, respectively, and in 4 (25%) and in 3 (19%) patients with a PIN at the ®rst biopsy. The medial initial PSA and follow-up PSA levels were signi®cantly greater in patients whose cancer was detected compared with those of patients whose cancer was not detected (8.5 AE 3.3 vs 22.8 AE 3.8 ng/ml, 7.9 AE 4.0 vs 20.5 AE 5.4 g/ml; P`0.05) only in the patients with the ®rst negative biopsy. The probability of prostate cancer detection in the second biopsy was not signi®cantly correlated to prostate size, PSA density, PSA velocity and presence of hypoechoic lesions which had already been biopsied (P b 0.05).
Conclusion
An overall positive re-biopsy rate of 16% in our retrospective series of 158 patients with a completely negative ®rst biopsy warrants the performance of a second biopsy in the presence of high PSA levels, despite the fact that we had already performed ten or more systematic TRUS biopsies according to prostate volume. The presence of a PIN has a predictive value in the diagnosis of prostatic cancer regardless of PSA levels.
